Many patients with Lynch syndrome remain undiagnosed, study finds

FHS
July 12, 2023
3:16 am

New research from Cedars-Sinai Cancer investigators could warrant reconsideration of current screening guidelines to include a poorly recognized cause of Lynch syndrome, the most common cause of hereditary colorectal and endometrial cancers.

Seaport Therapeutics Launches with $100 Million Oversubscribed Series a Financing Round to Advance Novel Neuropsychiatric Medicines | Psychedelic Invest

BOSTON – Seaport Therapeutics, a clinical-stage biopharmaceutical company that is charting a proven path in neuropsychiatry, today announced the closing of a $100 million oversubscribed Series A financing

April 10, 2024

Study finds gender disparity in quality of life for individuals with food allergies

Researchers examined the correlation between health-related quality of life (HRQL) and biological sex among individuals with immunoglobulin E (IgE)-related food allergies and their care providers.

February 9, 2024

4BIO pulls Development Bank of Japan to dip its toes into UK life science by backing latest fund

Japan’s sovereign investment bank has inked an investment agreement for VC firm 4BIO Capital’s third fund, marking the institutional investor’s initial venture into the UK

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.